CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang East Asia Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang East Asia Pharmaceutical Co Ltd
Yanhai Industrial Park
Pubagang Town, Sanmen County
Phone: +86 57689185661p:+86 57689185661 TAIZHOU, ZHJ  318020  China Ticker: 605177605177
Business Summary
Zhejiang East Asia Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw medicine and pharmaceutical intermediates. The Company's products mainly cover antibacterial drugs (including ß-lactams and quinolones), anticholinergic and synthetic antispasmodic drugs (including trimebutine maleate) and antifungal drugs for skin. The Company's anticholinergic and synthetic antispasmodics are mainly used to treat gastrointestinal smooth muscle spasm and functional gastrointestinal diseases. The Company distributes its products in domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager ChengChi 39 10/11/2024 9/1/2015
Finance Director XiaominWang 52 3/1/2008 3/1/2008
Deputy General Manager, Director DaominXia 61 6/7/2024 9/1/2015
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,577 (As of 12/31/2023)
Outstanding Shares: 114,753,580 (As of 9/30/2024)
Shareholders: 11,492
Stock Exchange: SHA
Fax Number: +86 57684285399


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024